After contentious debate, FDA approves first Alzheimer's drug since 2003


On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer's drug, aducanumab, developed by the drugmaker Biogen. The decision ... Read more

Bron: TechCrunch Green Blog
Tags:
Geplaatst: 07 Jun 2021 - 23:04